slides · global inventory
Transformation Tale
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,484
Current window 1,651-1,680
Pages 83
Rows per page 30
Arc
1,651-1,680 of 2,484
09
The table displays key financial metrics including Revenue, ECL, Operating expenses, Adjusted PBT, Significant items, Reported PBT, Customer loans, Customer accounts, and RWAs.HSBC | Investor Presentation Deck | 12 slides · HSBC
Conference presentation Investor relations Beat · Evidence1 hit
04
This is a brand-building/context slide using a photo collage to establish brand equity.Playboy | Investor Presentation Deck | 27 slides · Playboy
Pitch deck Investor relations Beat · ContextLoop · Golden Circle1 hit
05
The slide uses a map to visualize revenue concentration while listing five key performance indicators (KPIs) to the left.Playboy | Investor Presentation Deck | 27 slides · Playboy
Pitch deck Investor relations Beat · ContextLoop · Golden Circle1 hit
06
The slide uses a grid of photos to establish brand heritage and authority.Playboy | Investor Presentation Deck | 27 slides · Playboy
Pitch deck Investor relations Beat · ContextLoop · Golden Circle1 hit
08
The slide uses a numbered list format to present strategic pillars.Playboy | Investor Presentation Deck | 27 slides · Playboy
Pitch deck Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
01
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
02
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
03
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
04
The slide uses a three-column layout to summarize corporate actions.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
05
The slide uses a three-column layout to categorize corporate objectives.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
06
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
07
The slide uses two bar charts to illustrate growth trends over five quarters.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Quick Win Big Bet1 hit
08
The slide uses a line chart for hospital share and a combo bar/line chart for community share to illustrate market penetration.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
09
The slide outlines a clinical trial methodology using a timeline-based process flow.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
10
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
11
The slide uses a two-part structure: a top section for market sizing/segmentation and a bottom section for a competitive product comparison table.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
12
The chart is a forest plot showing LS Mean differences with 95% confidence intervals.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
13
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
14
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
15
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
16
The slide highlights specific cash flow activities like tax payments and share buybacks.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
17
The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
18
The table displays projected royalties and milestones for 2023-2026. The slide highlights the transition of royalty payments back to Theravance Biopharma starting in 2029.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
19
Uses a curved arrow diagram to represent a progression of value drivers.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
20
Slide 20 of the presentation.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
21
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
22
Includes a footnote regarding market research methodology.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
23
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
24
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
25
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit